| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Psychiatry (Drs. Andersen and Kragh–Sorensen), Odense University, Denmark; the Department of Epidemiology and Biostatistics (Drs. Hofman, Launer, Ott, and Stijnen), Erasmus University Medical School, Rotterdam, the Netherlands; the Department of Psychiatry (Drs. Copeland and Dewey), Royal Liverpool University Hospital, UK; INSERM Unit 330 (Dr. Dartigues and Letenneur), Bordeaux, France; the National Research Council Targeted Program on Ageing (Dr. Baldereschi), Florence, Italy; the Institute of Public Health (Dr. Brayne), Cambridge University, UK; and the Department of Psychiatry (Dr. Lobo), Zaragoza University, and the Department of Neurology (Dr. Martinez–Lage), University of Navarra, Pamplona, Spain.
Address correspondence and reprint requests to EURODEM, Department of Epidemiology & Biostatistics, Erasmus University Medical School, PO Box 1738, 3000DR Rotterdam, The Netherlands.
OBJECTIVE: To study the difference in risk for dementing diseases between men and women.
BACKGROUND: Previous studies suggest women have a higher risk for dementia than men. However, these studies include small sample sizes, particularly in the older age groups, when the incidence of dementia is highest.
METHODS: Pooled analysis of four population-based prospective cohort studies was performed. The sample included persons 65 years and older, 528 incident cases of dementia, and 28,768 person-years of follow-up. Incident cases were identified in a two-stage procedure in which the total cohort was screened for cognitive impairment, and screen positives underwent detailed diagnostic assessment. Dementia and main subtypes of AD and vascular dementia were diagnosed according to internationally accepted guidelines. Sex- and age-specific incidence rates, and relative and cumulative risks for total dementia, AD, and vascular dementia were calculated using log linear analysis and Poisson regression.
RESULTS: There were significant gender differences in the incidence of AD after age 85 years. At 90 years of age, the rate was 81.7 (95% CI, 63.8 to 104.7) in women and 24.0 (95% CI, 10.3 to 55.6) in men. There were no gender differences in rates or risk for vascular dementia. The cumulative risk for 65-year-old women to develop AD at the age of 95 years was 0.22 compared with 0.09 for men. The cumulative risk for developing vascular dementia at the age of 95 years was similar for men and women (0.04).
CONCLUSION: Compared with men, women have an increased risk for AD. There are no gender differences in risk for vascular dementia.
Key words: Epidemiology—Incidence study—Dementia—AD—Vascular dementia.
This article has been cited by other articles:
|
|
 |
|
  H. Gurvit, M. Emre, S. Tinaz, B. Bilgic, H. Hanagasi, H. Sahin, E. Gurol, J.T. Kvaloy, and H. Harmanci The Prevalence of Dementia in an Urban Turkish Population American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 67 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Miyashita, H. Arai, T. Asada, M. Imagawa, E. Matsubara, M. Shoji, S. Higuchi, K. Urakami, A. Kakita, H. Takahashi, et al. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females Hum. Mol. Genet., December 1, 2007; 16(23): 2854 - 2869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Fagan, C. M. Roe, C. Xiong, M. A. Mintun, J. C. Morris, and D. M. Holtzman Cerebrospinal Fluid tau/beta-Amyloid42 Ratio as a Prediction of Cognitive Decline in Nondemented Older Adults Arch Neurol, March 1, 2007; 64(3): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Gorospe and J. K. Dave The risk of dementia with increased body mass index Age Ageing, January 1, 2007; 36(1): 23 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yue, M. Lu, T. Lancaster, P. Cao, S.-I. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model PNAS, December 27, 2005; 102(52): 19198 - 19203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P Mooijaart, J. Gussekloo, M. Frolich, J. Jolles, D. J Stott, R. G. Westendorp, and A. J. de Craen Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus Study Am. J. Clinical Nutrition, October 1, 2005; 82(4): 866 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Baum Sex, Hormones, and Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 736 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Dalmonte, M. Bianchin, and E. Mariani Incidence and etiology of dementia in a large elderly Italian population Neurology, May 10, 2005; 64(9): 1525 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Assini, S. Cammarata, A. Vitali, M. Colucci, L. Giliberto, R. Borghi, M. L. Inglese, S. Volpe, S. Ratto, F. Dagna-Bricarelli, et al. Plasma levels of amyloid {beta}-protein 42 are increased in women with mild cognitive impairment Neurology, September 14, 2004; 63(5): 828 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singhal, S. Bevan, T. Barrick, P. Rich, and H. S. Markus The influence of genetic and cardiovascular risk factors on the CADASIL phenotype Brain, September 1, 2004; 127(9): 2031 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gustafson and I. Skoog Obesity and Alzheimer Disease: Roles of Diet and Genetics--Reply Arch Intern Med, January 12, 2004; 164(1): 110 - 110. [Full Text] [PDF]
|
|
|
|
|
|
D. Gustafson, E. Rothenberg, K. Blennow, B. Steen, and I. Skoog An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease Arch Intern Med, July 14, 2003; 163(13): 1524 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Zandi, M. C. Carlson, B. L. Plassman, K. A. Welsh-Bohmer, L. S. Mayer, D. C. Steffens, J. C. S. Breitner, and for the Cache County Memory Study Investigators Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women: The Cache County Study JAMA, November 6, 2002; 288(17): 2123 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Resnick and V. W. Henderson Hormone Therapy and Risk of Alzheimer Disease: A Critical Time JAMA, November 6, 2002; 288(17): 2170 - 2172. [Full Text] [PDF]
|
|
|
|
|
|
F. Forette, M.-L. Seux, J. A. Staessen, L. Thijs, M.-R. Babarskiene, S. Babeanu, A. Bossini, R. Fagard, B. Gil-Extremera, T. Laks, et al. The Prevention of Dementia With Antihypertensive Treatment: New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study Arch Intern Med, October 14, 2002; 162(18): 2046 - 2052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Miech, J. C.S. Breitner, P. P. Zandi, A. S. Khachaturian, J. C. Anthony, and L. Mayer Incidence of AD may decline in the early 90s for men, later for women: The Cache County study Neurology, January 22, 2002; 58(2): 209 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ch. Papasozomenos and A. Shanavas Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau : Implications for Alzheimer's disease PNAS, January 17, 2002; (2002) 32646799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-X. Tang, P. Cross, H. Andrews, D. M. Jacobs, S. Small, K. Bell, C. Merchant, R. Lantigua, R. Costa, Y. Stern, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan Neurology, January 9, 2001; 56(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rahkonen, R. Luukkainen-Markkula, S. Paanila, J. Sivenius, and R. Sulkava Delirium episode as a sign of undetected dementia among community dwelling elderly subjects: a 2 year follow up study J. Neurol. Neurosurg. Psychiatry, October 1, 2000; 69(4): 519 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kalmijn, D. Foley, L. White, C. M. Burchfiel, J. D. Curb, H. Petrovitch, G. W. Ross, R. J. Havlik, and L. J. Launer Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men : The Honolulu-Asia Aging Study Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2255 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ch. Papasozomenos and A. Shanavas Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau : Implications for Alzheimer's disease PNAS, February 5, 2002; 99(3): 1140 - 1145. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
